The 510(k) Mod Program, Breakthrough Technologies, and STeP


Instructor: John E Lincoln
Product ID: 706976
Training Level: Intermediate to Advanced

  • 7
  • August 2024
  • 10:00 AM PT | 01:00 PM ET
    Duration: 90 min
What are the U.S. FDA's recently expanded, less traditional / modified pathways for novel technologies or safer products to receive clearand or approval.

August 07, Wednesday 10:00 AM PT | 01:00 PM ET
Duration: 90 min


One Dial-in One Attendee

Group-Max. 10 Attendees/Location
(For multiple locations contact Customer Care)



1 Person Unlimited viewing for 6 month info Recorded Link and Ref. material will be available in My CO Section 48 hrs after completion of Live training
(For multiple locations contact Customer Care)

Downloadable file is for usage in one location only. info Downloadable link along with the materials will be emailed within 2 business days after completion of Live training
(For multiple locations contact Customer Care)



Customer Care

Fax: +1-650-362-2367

Email: [email protected]

Read Frequently Asked Questions


This webinar will consider the steps the FDA has been taken to provide different and more efficiant pathways for novel or safer technologies to receive FDA clearance or approval, e.g., the Medical Device Safety Action Plan, and recent updates to modernize and enhance the 510(k) and De Novo review processes.

In addition the Agency has further announced two additional device programs: 1) Finalizing guidance on the existing Breakthrough Device Program; and 2) Plans for a new Safer Technologies Program (STeP). Each addresses one of the two existing pathways, 510(k) and PMA, to address what the FDA calls "breakthrough technologies" using less restrictive submission requirements / pathways. Such approaches require a rethinking of submission strategies on the part of industry, to benefit from the FDA's changed thinking.

Why Should You Attend:

Over the past few years, the FDA has been developing new approaches to modernize FDA’s 510(k) clearance pathway, used for low- to moderate-risk devices that are substantially equivalent (SE) to a device already on the market, known as a predicate device. These changes include new pathways for these devices that the FDA has laid out and discussed in their Medical Device Safety Action Plan, issued April 16, 2018. The 510(k) pathway is used for the majority of devices that the FDA reviews.

Manufacturers often rely on comparative testing to predicate devices to demonstrate that a new device is substantially equivalent to the predicate. These new pathways expand the leeway for SE matches / comparisons, to allow for the clearance of "breakthrough technologies" or safer devices that pose reduced risks to the users, without having to go the De Novo or PMA submission route.

Areas Covered in the Webinar

  • FDA Commissioner’s Statements on Modernizing the 510(k)

  • The Medical Device Safety Action Plan

  • The Safer Technologies Program ... Draft Guidance
  • STeP, and Breakthrough Technologies

  • “Beneficial iteration” and the 510(k)
  • Proper implementation under this 510(k) “Pathway”
  • Meeting expectations before, during and after submission
  • The Q-Sub[mission] Program

  • Basic US FDA’s Expectations for the 510(k)

Who Will Benefit:

  • Senior management
  • Regulatory Affairs
  • Quality Assurance
  • Production
  • R&D and Engineering
  • All personnel involved in the U.S. FDA-regulated medical device (CGMPS) and submission environments. Especially those involved in new medical product / combination product development, line extensions, and incremental product improvements, especially novel technologies.
Instructor Profile:
John E Lincoln

John E Lincoln
Principal, J E Lincoln and Associates

John E. Lincoln, is Principal of J. E. Lincoln and Associates LLC, a consulting company with over 41 years experience in U.S. FDA-regulated industries, 27 years as head of his own consulting company. John has worked with companies from start-up to Fortune 100, in the U.S., Mexico, Canada, France, Germany, Sweden, China and Taiwan. He specializes in quality assurance, regulatory affairs, QMS problem remediation and FDA responses, new / changed product 510(k)s, process / product / equipment including QMS and software validations, ISO 14971 product risk management files / reports, Design Control / Design History Files, Technical Files. He's held positions in Manufacturing Engineering, QA, QAE, Regulatory Affairs, to the level of Director and VP (R&D). In addition, John has prior experience in military, government, electronics, and aerospace. He has published numerous articles in peer reviewed journals, 5 chapters in the RAPS textbook on validation, conducted workshops and webinars worldwide on CGMP subjects. John is a graduate of UCLA.

Follow us :



Refund Policy

Our refund policy is governed by individual products and services refund policy mentioned against each of offerings. However in absence of specific refund policy of an offering below refund policy will be effective.
Registrants may cancel up to two working days prior to the course start date and will receive a letter of credit to be used towards a future course up to one year from date of issuance. ComplianceOnline would process/provide refund if the Live Webinar has been cancelled. The attendee could choose between the recorded version of the webinar or refund for any cancelled webinar. Refunds will not be given to participants who do not show up for the webinar. On-Demand Recordings can be requested in exchange. Webinar may be cancelled due to lack of enrolment or unavoidable factors. Registrants will be notified 24hours in advance if a cancellation occurs. Substitutions can happen any time. On-Demand Recording purchases will not be refunded as it is available for immediate streaming. However if you are not able to view the webinar or you have any concern about the content of the webinar please contact us at below email or by call mentioning your feedback for resolution of the matter. We respect feedback/opinions of our customers which enables us to improve our products and services. To contact us please email [email protected] call +1-888-717-2436 (Toll Free).




6201 America Center Drive Suite 240, San Jose, CA 95002, USA

Follow Us

facebook twitter linkedin youtube


Copyright © 2023 MetricStream
Our Policies: Terms of use | Privacy

PAYMENT METHOD: 100% Secure Transaction

payment method